DistributorsPartnerships

iRemedy Introduces enterade® to its Marketplace

By June 18, 2019 October 29th, 2019 No Comments

NEW YORK, NY –  June 12th,  2019  – The iRemedy Healthcare Companies announced the addition of the enterade® Advanced Oncology Formula line of medical food drinks to their marketplace today. The clinically proven enterade® formula was designed to significantly reduce the debilitating gastrointestinal side effects of chemotherapy and radiation cancer treatment.

By helping to repair and restore normal gastrointestinal function, enterade® reduces dehydration and related diarrhea, leading to a significant improvement in the patient’s overall quality of life and a healthier GI tract. enterade® may help individuals maintain normal body weight, and therefore may help them better tolerate their full course of cancer therapy. enterade® is made with plant-based Amino BioActivs, is non-GMO, and does not contain artificial colors & flavors, sugar, or caffeine. All ingredients are GRAS (Generally Recognized As Safe), a designation used by the U.S. Food and Drug Administration to classify components of food that are safe and suitable for extensive use in the US population.  enterade® was originally developed to help NASA in the development and validation of biological countermeasures that protect astronauts from the adverse effects of ionizing radiation during long-duration deep space travel.

“Products like enterade® are invaluable in terms of making patients comfortable during their cancer therapy. It’s important to solve for side effects like gastrointestinal issues because it provides necessary relief and encourages patients to continue their treatments,” said iRemedy CEO Tony Paquin.

About iRemedy Healthcare Companies, Inc.
iRemedy is a privately-held healthcare technology and product distribution company that works with industry leaders, including Medline, McKesson, large hospitals, medical practices and GPOs, to bring data-driven intelligence to the U.S. medical supply chain. The iRemedy platform is a ‘smart’ ecommerce solution based on the proprietary iRemedy SKU Data Platform that includes product distribution services. This platform combines transaction, billing, medical record and other data to create a more intelligent product SKU. iRemedy’s solutions combine the power of ecommerce and full supply chain fulfillment services with AI and EHR-integrated capabilities to bring diversity of suppliers, price transparency, predictive analysis and just-in-time inventory solutions that more precisely meet the needs of healthcare providers, large and small.  For more information, please visit www.iremedy.com.

About Entrinsic Health Solutions, Inc.
enterade® is made by Entrinsic Health Solutions, a biotech company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases, through the discovery, development, and commercialization of therapies that restore and regulate disease causing protein dysregulation.

Company Contact:
Krys Graham
Director of Marketing
407-395-4283 | [email protected]

Entrinsic Health Solutions Contact:
Joe Del Regno
Chief Marketing Officer
401-787-7748 | [email protected]